Finding a Second Wind: Cystic Fibrosis

Overview

Antimicrobials are the cornerstone of modern medicine, and this is especially true for patients with cystic fibrosis. People with CF rely on antibiotics for recurring and persistent infections, and with regular use, antibiotics become less and less effective in fighting these infections. Pseudomonas aeroginosa, the most common culprit in CF infections, is especially notorious for its ability to adapt to and evade antibiotics. Hear from a patient advocate, clinician, and policy leader to better understand the unique challenges that superbugs pose for people battling cystic fibrosis.

Guests

• Ella Balasa: Patient Advocate and Engagement Consultant
• Helen Boucher, MD: Dean and Chief Academic Officer, Tufts University School of Medicine
• Mary Booth Dwight: Senior Vice President and Chief of Policy and Advocacy, Cystic Fibrosis Foundation

Resources

• Ella Balasa (Website)
• Tufts Levy CIMAR (Website)
• Championing a Sustainable Pipeline for Antibiotics (Cystic Fibrosis Foundation)
• Get Involved (Cystic Fibrosis Foundation)